Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate a previously FDA-approved medication that is known to help with allergy symptoms to see if it can decrease symptoms in patients with Meniere's Disease.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
House Ear Institute
Collaborators
NCT05365646 · Hearing Loss, Dizziness, and more
NCT06547372 · Atopic Dermatitis, Atopic, and more
NCT07419230 · Allergic Rhinitis
NCT07453615 · Anxiety, Fear Anxiety, and more
NCT07299487 · Vertigo
House Ear Clinic
Los Angeles, California
House Institute Foundation
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions